Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Banner Soflet Gelcaps aid anti-counterfeiting measures
Soflet Gelcaps is a unique, patented enrobing technology, originated by Banner, that provides tamper-evident security for valuable brand franchises at a cost of only pennies per tablet. The
Soflet Gelcaps is a unique, patented enrobing technology, originated by Banner, that provides tamper-evident security for valuable brand franchises at a cost of only pennies per tablet. The
Budesonide is an inhaled corticosteroid delivered by dry powder inhaler to children with mild persistent asthma. It is an active ingredient in AstraZeneca’s Pulmicort products. The findings are
Combunox (oxycodone HCl and ibuprofen) was approved by the FDA in November 2004 for the short-term (no more than seven days) management of acute, moderate to severe pain.
This National Cancer Institute (NCI)-sponsored phase II trial was designed to evaluate the efficacy and safety of HspE7 against CIN III (high grade cervical dysplasia). In the trial,
One set of interim results are from a phase II multi-center, international study designed to further evaluate clofarabine in older adult patients with acute myeloid leukemia (AML) who
The data was presented during the American Academy of Allergy, Asthma and Immunology’s (AAAAI) 61st annual meeting and came from two studies comparing Alvesco (ciclesonide) to fluticasone propionate
The committee review found that statistically significant longer progression-free survival was achieved in those patients administered BAY 43-9006 versus those patients administered placebo. As a result of this
Schering AG shares fell by over 14% and Novartis’ shares dropped nearly 3% on the news. However, although the analysis of progression free survival as assessed by central
The Global Forum, which was organized by Reconnaissance International, is the only congress in the world that brings together all the stakeholders from developing and industrialized countries. Attendees
The data, presented at The Annual Meeting of the American Academy of Allergy, Asthma and Immunology in San Antonio, Texas, demonstrated that a single low dose of the